FARALLON CAPITAL MANAGEMENT LLC – Enanta Pharmaceuticals, Inc. Transaction History
FARALLON CAPITAL MANAGEMENT LLC portfolio value:
$80.39M
portfolio value
FARALLON CAPITAL MANAGEMENT LLC quarter portfolio value change:
+9.73%
quarter
Enanta Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 7.13M | $51.87 | 1.55M | |
| Q2 2022 | share | 0.00% | 0 shares | -37.06M | $47.27 | 1.55M | |
| Q1 2022 | share | Decrease | -1.51% | -23.82K shares | -7.36M | $71.18 | 1.55M |
| Q4 2021 | share | Decrease | -21.11% | -421.17K shares | 4.35M | $74.57 | 1.57M |
| Q3 2021 | share | 0.00% | 0 shares | 25.53M | $56.81 | 1.99M | |
| Q2 2021 | share | 0.00% | 0 shares | -10.59M | $44.01 | 1.99M | |
| Q1 2021 | share | Increase | +12.39% | 220K shares | 23.66M | $49.32 | 1.99M |
| Q4 2020 | share | 0.00% | 0 shares | -6.53M | $42.1 | 1.77M | |
| Q3 2020 | share | Increase | +1.43% | 25K shares | -6.60M | $45.78 | 1.77M |
| Q2 2020 | share | 0.00% | 0 shares | -2.13M | $50.21 | 1.75M | |
| Q1 2020 | share | 0.00% | 0 shares | -18.11M | $51.43 | 1.75M | |
| Q4 2019 | share | Increase | +37.34% | 475.78K shares | 31.56M | $61.78 | 1.75M |
| Q3 2019 | share | Increase | +32.73% | 314.21K shares | -4.45M | $60.08 | 1.27M |
| Q2 2019 | share | Increase | +2.13% | 20K shares | -8.78M | $84.38 | 960K |
| Q1 2019 | share | Increase | +1.62% | 15K shares | 24.27M | $95.52 | 940K |
| Q4 2018 | share | Increase | +6.63% | 57.5K shares | -8.61M | $70.83 | 925K |
| Q3 2018 | share | Decrease | -19.30% | -207.5K shares | -50.45M | $85.46 | 867.5K |
| Q2 2018 | share | Increase | +17.49% | 160K shares | 50.56M | $115.9 | 1.07M |
| Q1 2018 | share | Decrease | -1.08% | -10K shares | 19.75M | $80.91 | 915K |
| Q4 2017 | share | Increase | +124.33% | 512.66K shares | 34.98M | $58.68 | 925K |
| Q3 2017 | share | Increase | 0.00% | 412.33K shares | 19.29M | $46.8 | 412.33K |